About Micelle BioPharma
Micelle BioPharma is a company based in Riviera Beach (United States) founded in 2018 was acquired by Strides Pharma Science in August 2019. Micelle BioPharma operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others.
- Headquarter Riviera Beach, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Strides Pharma Science
(Aug 01, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Micelle BioPharma
Detailed funding history for Micelle BioPharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Micelle BioPharma
Micelle BioPharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Strides Pharma Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic, semi-solid, and liquid dosage forms are manufactured.
|
Locked | Locked | Locked |
Investor details for Micelle BioPharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Micelle BioPharma
Investment portfolio details for Micelle BioPharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Micelle BioPharma
Detailed financials for Micelle BioPharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Micelle Biopharma Comparisons
Peer comparison for Micelle BioPharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Micelle BioPharma
Micelle BioPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| Locked | Locked | Locked |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| Locked | Locked | Locked |
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
Detailed competitors of Micelle BioPharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Micelle Biopharma
Complete news archive for Micelle BioPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Micelle BioPharma
Micelle BioPharma was founded in 2018.
Micelle BioPharma is headquartered in Riviera Beach, United States. It is registered at Riviera Beach, Florida, United States.
Founded in 2018, Micelle BioPharma is based in Riviera Beach, United States, and operates in the biopharmaceutical sector. Drugs for sickle cell disease in children are developed via the Advanced Lipid Technologies platform. The pipeline includes SC411 in phase II trials for SCD treatment, SC401 for managing high triglycerides linked to cardiovascular and liver issues, SC403 for addressing fatty acid malabsorption, and SC410 for non-alcoholic fatty liver disease and steatohepatitis.
Micelle BioPharma's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Micelle BioPharma has 1 investor. Key investors include Strides Pharma Science.